Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Oncol ; 42(3): 863-72, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23314732

ABSTRACT

Intracellular reactive oxygen species (ROS) such as hydrogen peroxide (H(2)O2()) are thought to mediate apoptosis induced by death receptor ligands, including tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). However, the role of H(2)O(2) is controversial, since some evidence suggests that H(2)O(2) acts as an anti-apoptotic factor. Here, we show that exogenously applied H(2)O(2) (30-100 µM) induces cell death in TRAIL-resistant human melanoma cells via intracellular superoxide (O(2)-) generation. H(2)O(2) induced apoptotic or necrotic cell death, depending on the concentration of the oxidant applied; low concentrations of H(2)O(2) preferentially activated the caspase-dependent apoptotic pathway, while high concentrations of H(2)O(2) induced apoptotic and necrotic cell death in a caspase-independent manner. The H(2)O(2)-induced cell death was associated with increased mitochondrial membrane potential collapse and caspase-3/7 activation and ER stress responses including caspase-12 and X-box-binding protein-1 (XBP-1) activation. H(2)O(2) induced intracellular O2- generation even within the mitochondria, while TRAIL did not. The superoxide dismutase mimetic antioxidant MnTBaP [Mn (III) tetrakis (4-benzonic acid) porphyrin chloride] inhibited the H(2)O(2)-induced O(2)- generation, apoptosis and XBP-1 and caspase-12 activation at comparable concentrations. Importantly, H(2)O(2) treatment caused minimal O(2)- generation and apoptosis in normal primary melanocytes. These data show that H(2)O(2) induces endoplasmic reticulum-associated cell death via intracellular O(2)- generation and that malignant melanoma cells are more susceptible than normal cells to this oxidative cell death. The findings suggest that H(2)O(2) has therapeutic potential in the treatment of TRAIL-resistant melanoma.


Subject(s)
Apoptosis/drug effects , Hydrogen Peroxide/pharmacology , Melanoma/metabolism , Superoxides/metabolism , TNF-Related Apoptosis-Inducing Ligand/metabolism , Caspase 12/drug effects , Caspase 12/metabolism , Caspase 3/metabolism , Caspase 7/metabolism , Cell Line, Tumor , DNA-Binding Proteins/drug effects , DNA-Binding Proteins/metabolism , Endoplasmic Reticulum Stress , Enzyme Activation , Free Radical Scavengers/pharmacology , Humans , Membrane Potential, Mitochondrial , Metalloporphyrins/pharmacology , Necrosis , Regulatory Factor X Transcription Factors , Transcription Factors/drug effects , Transcription Factors/metabolism , X-Box Binding Protein 1
3.
Dermatology ; 211(2): 159-61, 2005.
Article in English | MEDLINE | ID: mdl-16088166

ABSTRACT

We report a 63-year-old Japanese man with epilepsy who developed skin eruptions, liver dysfunction, high fever, leukocytosis and atypical lymphocytosis 4 weeks after he had started taking carbamazepine. Titers of human herpesvirus 7 (HHV-7)-specific IgG antibodies were significantly increased and HHV-7 DNA was detected in his serum by polymerase chain reaction. These findings suggested that reactivation of HHV-7 could contribute to the development of drug-induced hypersensitivity syndrome.


Subject(s)
Carbamazepine/adverse effects , Drug Hypersensitivity/diagnosis , Drug Hypersensitivity/etiology , Herpesvirus 7, Human/isolation & purification , Roseolovirus Infections/diagnosis , Carbamazepine/therapeutic use , DNA, Viral/analysis , Epilepsy/diagnosis , Epilepsy/drug therapy , Follow-Up Studies , Humans , Male , Middle Aged , Patch Tests , Polymerase Chain Reaction/methods , Prednisolone/therapeutic use , Recurrence , Risk Assessment , Roseolovirus Infections/drug therapy , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL
...